Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Impaired Platelet Aggregation and Rebalanced Hemostasis in Patients with Chronic Hepatitis C Virus Infection

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Methods and Guidelines for Measurement of Glucagon in Plasma

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Xeno-Free Propagation of Spermatogonial Stem Cells from Infant Boys

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion-A Review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Glucagon Receptor Signaling and Glucagon Resistance

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  5. Evolution and Medical Significance of LU Domain-Containing Proteins

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

Vis graf over relationer

Increased risk of both cardiovascular disease (CVD) and bleeding has been found in patients with chronic hepatitis C (CHC) infection, and a re-balanced hemostasis has been proposed. The aim of this study was to investigate functional whole blood coagulation and platelet function in CHC infection. The prospective study included 82 patients with CHC infection (39 with advanced liver fibrosis and 43 with no or mild liver fibrosis) and 39 healthy controls. A total of 33 patients were treated for CHC infection and achieved sustained virological response (SVR). Baseline and post-treatment blood samples were collected. Hemostasis was assessed by both standard coagulation tests and functional whole blood hemostatic assays (thromboelastograhy (TEG), and platelet aggregation (Multiplate). Patients with CHC and advanced fibrosis had impaired platelet aggregation both compared to patients with no or mild fibrosis and to healthy controls. Patients with CHC and advanced fibrosis also had lower antithrombin, platelet count, and coagulation factors II-VII-X compared to healthy controls. In contrast, TEG did not differ between groups. In treated patients achieving SVR, post-treatment platelet count was higher than pre-treatment counts (p = 0.033) and ADPtest, ASPItest, and RISTOhightest all increased post treatment (all p < 0.05). All Multiplate tests values, however, remained below those in the healthy controls. CHC-infected patients displayed evidence of rebalanced hemostasis with only partly hemostatic normalization in patients achieving SVR. The implications of rebalanced hemostasis and especially the impact on risk of CVD and bleeding warrants further studies.

OriginalsprogEngelsk
Artikelnummer1016
TidsskriftInternational Journal of Molecular Sciences
Vol/bind18
Udgave nummer5
Sider (fra-til)e1016
ISSN1661-6596
DOI
StatusUdgivet - 8 maj 2017

ID: 52592193